Non-contrast Lung Perfusion Mapping Applied for New Insights in Cystic Fibrosis

NCT04467957 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: Initiation of CFTR Modulator
DRUG: Hyperpolarized Xenon 129

Sponsor

Children's Hospital Medical Center, Cincinnati